Quince Therapeutics reported raising $115 Million in an initial SEC Form D filing, from an offering of $186 Million
PUBLIC · IRLAJun 11, 2026$114.7M of $186.4M raised
Round Type
Venture
New HavenBiotechnologyHealthcareHealth CareTherapeuticsInvestors
Cormorant Asset ManagementJanus HendersonLogos CapitalPerceptive AdvisorsBalyasny Asset Management
Who to call at IRulya Therapeutics Inc., and when
A new round usually means IRulya Therapeutics Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day IRulya Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IRulya Therapeutics Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IRulya Therapeutics Inc.. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IRulya Therapeutics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
IRulya Therapeutics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.